Company press releases

Displaying 51 - 100 of 114 results
Released Company Title Industry Topic
06 Sep 2023
07:30 CEST 		THERAVET TheraVet Reports Its 2023 Half-year Results and Provides an Update on the Development of Its Activities 20103015 Pharmaceuticals Sales
06 Sep 2023
07:30 CEST 		THERAVET TheraVet publie ses résultats financiers du 1er semestre 2023 et fait le point sur le développement de ses activités 20103015 Pharmaceuticals Sales
11 Jul 2023
07:30 CEST 		THERAVET TheraVet provides an update on its 2023 half-year development and portfolio strategy 20103015 Pharmaceuticals New
11 Jul 2023
07:30 CEST 		THERAVET TheraVet fait le point sur son développement et sa stratégie de portefeuille au premier semestre 2023 20103015 Pharmaceuticals New
15 Jun 2023
07:30 CEST 		THERAVET TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago 20103015 Pharmaceuticals Other subject
15 Jun 2023
07:30 CEST 		THERAVET TheraVet annonce une augmentation de 300 % du nombre de centres participant au programme dédié à l’ostéosarcome depuis son lancement il y a six mois 20103015 Pharmaceuticals Other subject
31 May 2023
07:30 CEST 		THERAVET TheraVet annonce le lancement commercial d'un substitut osseux à libération locale et prolongée d'antibiotiques 20103015 Pharmaceuticals Products and services
31 May 2023
07:30 CEST 		THERAVET TheraVet Announces the Commercial Launch of a Local and Sustained Antibiotic Releasing Bone Substitute 20103015 Pharmaceuticals Products and services
04 May 2023
07:30 CEST 		THERAVET TheraVet Continues the Assessment of BIOCERA-VET in a New Clinical Program 20103015 Pharmaceuticals Other subject
04 May 2023
07:30 CEST 		THERAVET TheraVet poursuit l'évaluation de BIOCERA-VET dans un nouveau programme clinique 20103015 Pharmaceuticals Other subject
25 Apr 2023
07:30 CEST 		THERAVET TheraVet publie ses résultats annuels pour l’exercice 2022 et met à disposition les documents préparatoires pour l’Assemblée Générale du 1er juin 2023 20103015 Pharmaceuticals Sales
25 Apr 2023
07:30 CEST 		THERAVET TheraVet reports Full-Year 2022 Financial Results and provides the preparatory documents for the General Assembly of June 1st, 2023 20103015 Pharmaceuticals Sales
06 Apr 2023
07:30 CEST 		THERAVET TheraVet Launches its Osteosarcoma Reference Centers Program 20103015 Pharmaceuticals Other subject
06 Apr 2023
07:30 CEST 		THERAVET TheraVet annonce le lancement de son programme de Centres de Référence dédié à l'Ostéosarcome 20103015 Pharmaceuticals Other subject
28 Mar 2023
07:30 CEST 		THERAVET TheraVet Updates on Its Development and Portfolio Strategy 20103015 Pharmaceuticals Other subject
28 Mar 2023
07:30 CEST 		THERAVET TheraVet fait le point sur sa stratégie de développement et de portefeuille produits 20103015 Pharmaceuticals Other subject
21 Feb 2023
07:30 CET 		THERAVET TheraVet Signs an International Distribution Agreement for BIOCERA-VET® Covering 24 Countries 20103015 Pharmaceuticals News contracts
21 Feb 2023
07:30 CET 		THERAVET TheraVet signe un accord de distribution à l’international pour BIOCERA-VET® couvrant 24 pays 20103015 Pharmaceuticals News contracts
15 Feb 2023
17:45 CET 		THERAVET TheraVet Announces the Start of the Assessment of BIOCERA-VET® in Horse Bone Cyst 20103015 Pharmaceuticals Other subject
15 Feb 2023
17:45 CET 		THERAVET TheraVet annonce le début de l'évaluation de BIOCERA-VET® dans le traitement du kyste osseux chez le cheval 20103015 Pharmaceuticals Other subject
12 Dec 2022
07:30 CET 		THERAVET TheraVet Optimizes Its Commercial Strategy in France With a New Distribution Agreement for Its BIOCERA-VET® Range 20103015 Pharmaceuticals News contracts
12 Dec 2022
07:30 CET 		THERAVET TheraVet optimise sa stratégie commerciale en France avec un nouvel accord de distribution pour sa gamme BIOCERA-VET® 20103015 Pharmaceuticals News contracts
07 Dec 2022
07:30 CET 		THERAVET TheraVet : BIOCERA-VET® nominé au Prix de l’Innovation Vétérinaire (AFVAC 2022) 20103015 Pharmaceuticals Other subject
07 Dec 2022
07:30 CET 		THERAVET TheraVet: BIOCERA-VET® Nominated for the Veterinary Innovation Award (AFVAC 2022) 20103015 Pharmaceuticals Other subject
26 Sep 2022
07:30 CEST 		THERAVET TheraVet annonce un accord de distribution exclusif pour BIOCERA-VET® aux États-Unis 20103015 Pharmaceuticals News contracts
26 Sep 2022
07:30 CEST 		THERAVET TheraVet Announces an Exclusive Distribution Agreement for BIOCERA-VET® in the USA 20103015 Pharmaceuticals News contracts
19 Sep 2022
07:30 CEST 		THERAVET TheraVet annonce sa participation au congrès de l’ESVOT 2022 avec 3 communications scientifiques 20103015 Pharmaceuticals Meetings / events
19 Sep 2022
07:30 CEST 		THERAVET TheraVet Announces Its Participation in the 2022 ESVOT Congress With 3 Scientific Communications 20103015 Pharmaceuticals Meetings / events
09 Sep 2022
07:30 CEST 		THERAVET TheraVet Reports Its 2022 Half-year Results and Provides an Update on the Development of Its Activities 20103015 Pharmaceuticals Other subject
09 Sep 2022
07:30 CEST 		THERAVET TheraVet publie ses résultats financiers du 1er semestre 2022 et fait le point sur le développement de ses activités 20103015 Pharmaceuticals Other subject
30 Jun 2022
17:45 CEST 		THERAVET TheraVet Provides Its 2022 First Half-year Operational Update 20103015 Pharmaceuticals Other subject
30 Jun 2022
17:45 CEST 		THERAVET TheraVet publie son point d’activité du 1er semestre 2022 20103015 Pharmaceuticals Other subject
30 Jun 2022
07:30 CEST 		THERAVET TheraVet Annonces the Commercial Launch of its BIOCERA-VET Product Line in the United States of America 20103015 Pharmaceuticals Other subject
30 Jun 2022
07:30 CEST 		THERAVET TheraVet annonce le lancement commercial de sa gamme de produits BIOCERA-VET® aux États-Unis 20103015 Pharmaceuticals Other subject
02 Jun 2022
07:30 CEST 		THERAVET TheraVet Annonces the Commercial Launch of the Most Comprehensive Line of Bone Substitutes in the Veterinary Market 20103015 Pharmaceuticals Other subject
02 Jun 2022
07:30 CEST 		THERAVET TheraVet annonce le lancement de la gamme de substituts osseux la plus complète pour le marché vétérinaire 20103015 Pharmaceuticals Other subject
30 May 2022
07:30 CEST 		THERAVET TheraVet Signs a Distribution Agreement With Nuzoa, a Leading Spanish Company in the Distribution of Veterinary Products and Services 20103015 Pharmaceuticals Other subject
30 May 2022
07:30 CEST 		THERAVET TheraVet signe un accord de distribution avec Nuzoa, une société espagnole leader dans la distribution de produits et services vétérinaires 20103015 Pharmaceuticals Other subject
12 May 2022
07:30 CEST 		THERAVET TheraVet: General Meeting of June 2, 2022: Availability of Preparatory Documents 20103015 Pharmaceuticals Other subject
12 May 2022
07:30 CEST 		THERAVET TheraVet : Assemblée générale du 2 juin 2022 : mise à disposition des documents préparatoires 20103015 Pharmaceuticals Other subject
10 May 2022
07:30 CEST 		THERAVET TheraVet signe un important accord de distribution avec le distributeur d’instruments orthopédiques et chirurgicaux Veterinary Instrumentation 20103015 Pharmaceuticals Other subject
10 May 2022
07:30 CEST 		THERAVET TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation 20103015 Pharmaceuticals Other subject
06 Apr 2022
07:30 CEST 		THERAVET TheraVet publie ses résultats annuels de l’exercice 2021 et confirme ses perspectives ambitieuses de développement et de commercialisation pour 2022 20103015 Pharmaceuticals Other subject
06 Apr 2022
07:30 CEST 		THERAVET TheraVet Reports Full Year 2021 Financial Results and Confirms Its Ambitious Development and Commercial Plans for 2022 20103015 Pharmaceuticals Other subject
28 Mar 2022
07:30 CEST 		THERAVET TheraVet: Market-making Agreement with Banque Rothschild 20103015 Pharmaceuticals Other subject
28 Mar 2022
07:30 CEST 		THERAVET TheraVet : Mise en œuvre d’un contrat d’animation de marché avec la banque Rothschild 20103015 Pharmaceuticals Other subject
15 Mar 2022
07:30 CET 		THERAVET TheraVet: Commercial Launch of BIOCERA-VET® in United Kingdom and Ireland 20103015 Pharmaceuticals Other subject
15 Mar 2022
07:30 CET 		THERAVET TheraVet : Lancement commercial de BIOCERA-VET® au Royaume-Uni et en Irlande 20103015 Pharmaceuticals Other subject
07 Feb 2022
07:30 CET 		THERAVET TheraVet élargit son portefeuille de substituts osseux avec une gamme innovante de greffons biologiques 20103015 Pharmaceuticals Other subject
07 Feb 2022
07:30 CET 		THERAVET TheraVet Broadens Its Bone Substitutes Portfolio With an Innovative Line of Biological Bone Grafts 20103015 Pharmaceuticals Other subject